FolioLanternBeta
IRDOpus Genetics, Inc.

Robert Gagnon

Chief Financial Officer at Opus Genetics, Inc., as of Sep 8, 2026Sold $191K of stock in the past 12 months: 67% under a disclosed plan and 33% to cover taxes.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
44K
shares sold, past 12 months
3
days with sales
$127K
largest single day, Sep 3, 2026
3
companies filed for

Share of stake sold and shares held at Opus Genetics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarApr 2026: $41K to cover taxesAprMayJunJul 2026: $23K to cover taxesJulAugSep 2026: $127K under a disclosed plan$127KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Opus Genetics, Inc. (IRD)Chief Financial OfficerSep 11, 2025Sep 8, 2026
Clean Harbors Inc (CLH)Former EVP CFO and TreasurerAug 22, 2012Sep 13, 2012
Biogen (BIIB)Former Vice President, FinanceNov 10, 2010Mar 1, 2012

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.